main
atyp
pathogen
respiratori
tract
infect
classifi
basi
abil
caus
atyp
pneumonia
welldefin
clinic
entiti
evid
atyp
pathogen
sometim
caus
typic
pneumonia
vice
versa
emphas
need
microbiolog
diagnosi
sinc
affect
select
proper
treatment
plactam
antibiot
aminoglycosid
effect
moreov
mix
infect
caus
atyp
typic
pathogen
togeth
common
moment
rapid
sensit
diagnost
method
lack
besid
numer
virus
main
bacteri
pathogen
caus
atyp
pneumonia
mycoplasma
pneumonia
two
chlamydi
speci
chlamydia
pneumonia
c
psittaci
one
rickettsia
coxiella
burnetti
sever
legionella
speci
major
pathogen
caus
upper
respiratori
tract
infect
often
overt
pneumonia
atyp
agent
chlamydia
pneumonia
also
associ
chronic
inflammatori
condit
cardiovascular
system
recent
discov
pathogen
atyp
pneumonia
hantaviru
caus
hantaviru
pulmonari
syndrom
atyp
pathogen
communityacquir
respiratori
tract
infect
pure
microbiolog
entiti
apart
pneumonia
pneumococcu
lead
caus
agent
overwhelm
major
respiratori
infect
caus
atyp
pathogen
tabl
list
atyp
pathogen
long
microbi
diagnost
method
use
pathogen
found
recent
exampl
compris
hantavirus
recent
found
hantaviru
pulmonari
syndrom
l
although
pneumonia
pneumon
symptom
earlier
describ
hantaviru
infect
pulmonari
edema
rickettsios
one
expect
hemorrhag
fever
viru
caus
agent
sever
pneumonia
use
advanc
microbi
diagnost
method
establish
new
diseas
syndrom
histori
atyp
pathogen
start
psittacosi
caus
chlamydia
psittaci
influenza
virus
q
fever
caus
rickettsia
coxiella
burnetti
influenza
viru
continu
great
scourg
mankind
possibl
appear
new
killer
strain
everi
autumn
greater
menac
fear
ebola
viru
two
agent
also
continu
import
respiratori
tract
pathogen
zoonos
limit
occurr
mostli
case
anim
contact
luckili
atyp
pneumonia
usual
clinic
sever
rather
convers
case
clinic
featur
atyp
pneumonia
present
tabl
patient
histori
famili
case
epidemiolog
situat
aid
diagnosi
well
contact
sick
parrot
suspicion
psittacosi
onset
delay
insidi
sputum
product
nlinim
polymorphonuclear
leukocyt
present
chest
xray
lobar
infiltr
diffus
alter
typic
atyp
pneumonia
seen
leukocytosi
absent
case
without
massiv
pulmonari
destruct
erythrocyt
sediment
level
usual
elev
creactiv
protein
reach
level
found
especi
sever
pneumococc
pneumonia
howev
none
symptom
sign
readili
differenti
atyp
diseas
typic
one
u
valu
overlap
even
lobar
infiltr
xray
caus
atyp
pathogen
without
proper
microbi
diagnosi
first
clue
etiolog
often
lack
respons
standard
antimicrobi
treatment
use
follow
section
main
bacteri
agent
caus
atyp
respiratori
tract
infect
discuss
special
emphasi
latest
bacteri
addit
chlamydia
pneumonia
mycoplasm
pneumonia
concentr
younger
age
group
illustr
figur
compar
preval
antibodi
pneumonia
chlamydia
pneumonia
finnish
popul
clinic
descript
mycoplasm
infect
classic
open
question
one
lack
reliabl
diagnost
method
sinc
convent
serolog
method
coldagglutinin
complementfix
test
neither
sensit
specif
although
former
easi
perform
second
question
effect
antibiot
treatment
mycoplasm
pneumonia
mycoplasm
diseas
gener
neglect
area
reli
serolog
diagnosi
mycoplasm
pneumonia
epidem
curiou
diseas
name
afterward
legionellosi
pittsburgh
brought
special
bacteri
genu
attent
although
first
member
discov
thirti
year
earlier
lo
discov
caus
agent
sever
seriou
epidem
respiratori
infect
rel
new
also
associ
environment
construct
aircondit
tech
associ
clinic
diseas
especi
sever
pneumonia
import
environment
bacteria
vari
consider
differ
region
set
place
caus
consider
proport
pneumonia
list
among
three
major
caus
area
eg
finland
despit
intens
search
rariti
usual
import
tourist
respiratori
tract
infect
caus
chlamydia
psittaci
directli
depend
exposur
bird
carri
pathogen
therefor
case
seen
connect
curkci
duck
farm
chicken
seem
iziport
pigeon
breed
sick
pet
bird
casual
contact
synanthrop
bird
common
rule
bird
contact
much
difficult
find
one
debat
whether
chlamydia
pneumonia
common
agent
chlamydia
psittaci
even
microimmunofluoresc
mif
test
sometim
difficult
differenti
two
chlamydi
speci
demand
expertis
fortun
treatment
chlamydi
pneumonia
accord
seroepidemiolog
survey
chlamydia
pneumonia
infect
time
common
chlamydia
psitfari
infect
possibl
sever
chlamydia
psittaci
infect
could
due
sensit
patient
speci
earlier
mild
chlamydia
pneumonia
pulmonari
infect
recent
addit
long
list
import
atyp
bacteri
pathogen
chlamydia
przeumonia
like
first
legionella
strain
first
strain
new
chlaniydi
agent
isol
year
epidem
northern
finland
brought
attent
begin
chlamydia
ptzeumonia
seem
agent
caus
beiiign
mild
diseas
later
shown
causeth
typic
featur
chlamydiasil
slowli
creep
infect
gradual
lead
sever
tissu
damag
pathogenesi
chlamydia
przeumonia
infect
studi
use
mous
model
chlamydia
pneumonia
given
intranas
acut
infect
polymorphonuclear
leukocyt
lung
seen
massiv
challeng
dose
otherwis
silent
pneumon
clear
histolog
pictur
mononuclear
inflamm
around
bronchiol
vessel
develop
without
overt
ill
repeat
inocul
aggrav
inflamm
temporarili
presenc
agent
difficult
demonstr
isol
demonstr
nucleic
acid
polymeras
chain
reaction
pcr
give
howev
posit
find
cortison
treatment
allevi
inflamm
make
isol
agent
possibl
chlamydia
pneumonia
also
demonstr
intranas
challeng
blood
circul
alveolar
periton
macrophag
liver
spleen
point
dissemin
infect
upper
respiratori
tract
carriag
describ
possibl
carrier
develop
antibodi
respons
prolong
period
pneumonia
due
chlamydia
pneumonia
haw
describ
infant
japan
report
epidem
daycar
centr
howev
industri
countri
antibodi
usual
start
appear
children
enter
school
recent
finnish
studi
childhood
pneumonia
youngest
patient
chlamydia
pneumonia
infect
year
old
major
patient
year
age
korppi
et
al
unpublish
data
respiratori
syndrom
associ
chlamydia
pneumonia
rhiniti
sinus
pharyng
otiti
bronchiti
recent
review
chlamydia
peumonia
infect
children
concentr
respiratori
tract
infect
howev
chlamydia
pneumonia
epidem
northern
finland
third
children
present
seroconvers
hospit
respiratori
tract
symptom
uhari
et
al
unpublish
data
diseas
pictur
children
thu
quit
variabl
demand
studi
primari
infect
young
adult
lead
pneumonia
case
usual
mild
diseas
prolong
long
convalesc
young
age
group
reinfect
seem
lead
pneumonia
howev
reinfect
pneumonia
especi
elderli
patient
underli
diseas
sever
one
possibl
resist
infect
decreas
enough
allow
agent
invad
lung
invad
strain
differ
enough
abl
colon
lung
partial
immun
lead
hypersensit
reaction
typic
infect
role
chlamydia
pneumonia
play
acut
respiratori
tract
infect
still
studi
adult
associ
pharyng
case
last
figur
epidem
acut
bronchiti
case
sinus
otiti
adult
also
report
wider
studi
far
lack
mix
infect
coninion
chlamydia
p
mrnonia
infect
studi
finnish
children
half
even
major
patient
concomit
infect
caus
anoth
pathogen
viru
mycoplasma
bacterium
similarli
epidem
north
finland
nearli
half
chlamydia
pneumonia
pneumonia
combin
invas
pneumococc
infect
chlamydia
pneumonia
ciliostat
effect
case
may
help
pneumococci
carri
upper
respiratori
tract
invad
deeper
layer
doubl
infect
sever
usual
respons
antibiot
effect
pneumococcu
poor
one
satisfi
one
pathogen
diagnos
alway
keep
mind
possibl
mix
infect
serolog
tradit
use
diagnos
infect
caus
atyp
pathogen
antigen
complet
kit
antibodi
assay
commerci
avail
sever
sourc
seriou
disadvantag
need
demonstr
seroconvers
major
case
delay
diagnosi
aid
clinician
treat
acut
ill
patient
attempt
made
overcom
delay
demonstr
igm
antibodi
acut
phase
use
diagnost
high
titer
first
serum
sampl
pitfal
lack
igm
reinfect
uncertainti
diagnost
valu
high
titer
acut
diseas
caus
sever
atyp
agent
serolog
even
though
inadequ
remain
main
diagnost
tool
mycoplasm
pneumonia
well
q
fever
cultur
atyp
pathogen
demand
special
media
wide
use
microbiolog
laboratori
case
obligatori
intracellular
pathogen
cultur
live
cell
special
unit
moreov
coxiella
burnetti
chlamydia
psittaci
present
danger
laboratori
worker
handl
agent
even
chlamydia
pneumonia
caus
laboratoryacquir
pneumonia
legionellosi
howev
cultur
standard
diagnost
procedur
also
attempt
chlamydia
pneumonia
infect
order
obtain
inform
diseas
associ
strain
variabl
newli
recogn
pathogen
antigen
detect
respiratori
tract
infect
util
mainli
viral
infect
good
success
use
case
atyp
bacteri
pathogen
reward
moreov
techniqu
base
immunofluoresc
demand
experi
patienc
reader
sinc
number
pathogen
often
limit
reliabl
identif
difficult
lack
commerci
avail
reagent
lut
problem
diagnosi
uncommon
atyp
pathogen
howev
legionellosi
detect
antigen
urin
seem
reliabl
diagnost
method
pneumonia
presenc
ofbacteri
compon
circul
alon
immun
complex
use
success
diagnosi
pneumococc
pneumonia
remain
unstudi
case
atyp
pathogen
type
complex
commonli
seen
howev
chronic
chlamydia
pneumonia
infect
lessen
diagnost
valu
acut
infect
especi
elderli
male
arteriosclerot
lesion
nucleic
acid
na
detect
seem
diagnost
method
futur
atyp
respiratori
pathogen
commerci
kit
pneumonia
direct
na
detect
longer
avail
diagnost
compani
develop
kit
base
na
amplif
legionella
spp
pneumonia
chlamydia
pneumonia
whether
base
polymeras
ligas
chain
reaction
would
provid
sensit
specif
diagnosi
pathogen
h
would
final
give
firm
basi
ration
target
therapi
tabl
show
recommend
treatment
infect
caus
atyp
pathogen
therapeut
respons
bacteri
atyp
pathogen
plactam
antibiot
aminoglycosid
lack
margin
drug
use
tetracyclin
macrolid
azalid
time
tell
much
advent
newer
quinolon
alter
recommend
prolong
treatment
week
use
legionellosi
chlamydia
pneumonia
pneumonia
possibl
mix
infect
alway
kept
mind
appropri
therapi
effici
prevent
longterm
sequela
caus
atyp
pathogen
q
fever
endocard
fear
complic
often
lead
valvular
oper
drug
therapi
rest
patient
life
recent
discov
chlamydia
pneumonia
seem
associ
complic
unexpect
sever
ubiqu
sign
chronic
chlamydia
pneumonia
infect
found
childhood
adultonset
asthma
chronic
bronchiti
sarcoidosi
surpris
associ
arteriosclerosi
lead
caus
death
industri
countri
marker
chronic
chlamydia
yneumonia
infect
found
acut
myocardi
infarct
repeatedli
shown
risk
factor
cardiac
event
final
pathogen
demonstr
atherosclerot
lesion
anim
experi
posit
preliminari
intervent
trial
may
possibl
appropri
treatment
chlavnydin
pneumonia
respiratori
infect
acut
phase
prevent
infect
progress
chronic
state
much
difficult
cure
would
demand
acut
diagnosi
target
therapi
atyp
pneumonia
